A γ-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells

Virology

Volumn 353, Issue 1, 2006, Pages 210-219

  Tibbetts, Scott A ^a   Suarez, Felipe ^a   Steed, Ashley L ^a   Simmons, Jacob A ^a   Virgin IV, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attenuated; Defective; Herpesvirus; Immunity; Murine; Replication; T cell

Indexed keywords

DNA BINDING PROTEIN; ORF6 PROTEIN; PROTEIN; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENE MUTATION; HERPES VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; VIRUS REPLICATION; WILD TYPE;

ANIMALS; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; IMMUNITY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NIH 3T3 CELLS; T-LYMPHOCYTES; VIRUS LATENCY; VIRUS REPLICATION;

HERPESVIRIDAE; MURINAE;

EID: 33748178964     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.05.020     Document Type: Article

References (53)

1. Adler H., Messerle M., Wagner M., and Koszinowski U.H. Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J. Virol. 74 (2000) 6964-6974
2. Adler H., Messerle M., and Koszinowski U.H. Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences. J. Virol. 75 (2001) 5692-5696
3. Augustinova H., Hoeller D., and Yao F. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice. J. Virol. 78 (2004) 5756-5765
4. Babcock G.J., Decker L.L., Freeman R.B., and Thorley-Lawson D.A. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J. Exp. Med. 190 (1999) 567-576
5. Bayliss G.J., Marsden H.S., and Hay J. Herpes simplex virus proteins: DNA-binding proteins in infected cells and in the virus structure. Virology 68 (1975) 124-134
6. Braaten D.C., Sparks-Thissen R.L., Kreher S., Speck S.H., and Virgin H.W. An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection. J. Virol. 79 (2005) 2573-2583
7. Cardin R.D., Brooks J.W., Sarawar S.R., and Doherty P.C. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J. Exp. Med. 184 (1996) 863-871
8. Christensen J.P., Cardin R.D., Branum K.C., and Doherty P.C. CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc. Natl. Acad. Sci. 96 (1999) 5135-5140
9. Clambey E.T., Virgin H.W., and Speck S.H. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J. Virol. 74 (2000) 1973-1984
10. Da Costa X.J., Jones C.A., and Knipe D.M. Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6994-6998
11. Ehtisham S., Sunil-Chandra N.P., and Nash A.A. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67 (1993) 5247-5252
12. Fixman E.D., Hayward G.S., and Hayward S.D. trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J. Virol. 66 (1992) 5030-5039
13. Flano E., Jia Q., Moore J., Woodland D.L., Sun R., and Blackman M.A. Early establishment of gamma-herpesvirus latency: implications for immune control. J. Immunol. 174 (2005) 4972-4978
14. Gangappa S., Kapadia S.B., Speck S.H., and Virgin H.W. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J. Virol. 76 (2002) 11460-11468
15. Gangappa S., Van Dyk L.F., Jewett T.J., Speck S.H., and Virgin H.W. Identification of the in vivo role of a viral bcl-2. J. Exp. Med. 195 (2002) 931-940
16. Godowski P.J., and Knipe D.M. Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 256-260
17. Grusby M.J., Johnson R.S., Papaioannou V.E., and Glimcher L.H. Depletion of CD4 T cells in major histocompatibility complex class II-deficient mice. Science 253 (1991) 1417-1420
18. Jia Q.M., Wu T.T., Liao H.I., Chernishof V., and Sun R. Murine gammaherpesvirus 68 open reading frame 31 is required for viral replication. J. Virol. 78 (2004) 6610-6620
19. Kapadia S.B., Molina H., van B.V., Speck S.H., and Virgin H.W. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J. Virol. 73 (1999) 7658-7670
20. Karber G. Beitrag zar Kollktiven Behandlung Pharmakologischer Reiherersuche. Arch. Exp. Patho. Pharmakol. 162 (1931) 480-483
21. Lee C.K., and Knipe D.M. An immunoassay for the study of DNA-binding activities of herpes simplex virus protein ICP8. J. Virol. 54 (1985) 731-738
22. Littler E., Purifoy D., Minson A., and Powell K.L. Herpes simplex virus non-structural proteins: III. Function of the major DNA-binding protein. J. Gen. Virol. 64 (1983) 983-995
23. MacDonald M.R., Li X.Y., Stenberg R.M., Campbell A.E., and Virgin H.W. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant. J. Virol. 72 (1998) 442-451
24. McClellan J.S., Tibbetts S.A., Gangappa S., Brett K.A., and Virgin H.W. Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gamma-herpesvirus latency. J. Virol. 78 (2004) 6836-6845
25. Mombaerts P., Clarke A.R., Rudnicki M.A., Iacomini J., Itohara S., Lafaille J.J., Wang L.L., Ichikawa Y., Jaenisch R., Hooper M.L., and Tonegawa S. Mutations in T-cell antigen receptor genes alpha-block and beta-block thymocyte development at different stages. Nature 360 (1992) 225-231
26. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., and Papaioannou V.E. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68 (1992) 869-877
27. Moorman N.J., Lin C.Y., and Speck S.H. Identification of candidate gammaherpesvirus 68 genes required for virus replication by signature-tagged transposon mutagenesis. J. Virol. 78 (2004) 10282-10290
28. Morrison L.A., and Knipe D.M. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. J. Virol. 68 (1994) 689-696
29. Morrison L.A., and Knipe D.M. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1. Virology 239 (1997) 315-326
30. Moser J.M., Farrell M.L., Krug L.T., Upton J.W., and Speck S.H. A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge. J. Virol. 80 (2006) 1592-1598
31. Nguyen L.H., Knipe D.M., and Finberg R.W. Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J. Virol. 66 (1992) 7067-7072
32. Powell K.L., and Purifoy D.J. DNA-binding proteins of cells infected by herpes simplex virus type 1 and type 2. Intervirology 7 (1976) 225-239
33. Roizman B. The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11307-11312
34. Simas J.P., Bowden R.J., Paige V., and Efstathiou S. Four tRNA-like sequences and a serpin homologue encoded by murine gammaherpesvirus 68 are dispensable for lytic replication in vitro and latency in vivo. J. Gen. Virol. 79 (1998) 149-153
35. Simas J.P., Swann D., Bowden R., and Efstathiou S. Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection. J. Gen. Virol. 80 (1999) 75-82
36. Smith G.A., and Enquist L.W. Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J. Virol. 73 (1999) 6405-6414
37. Song M.J., Hwang S.M., Wong W.H., Wu T.T., Lee S.M., Liao H.I., and Sun R. Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3805-3810
38. Sparks-Thissen R.L., Braaten D.C., Kreher S., Speck S.H., and Virgin H.W. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J. Virol. 78 (2004) 6827-6835
39. Stevenson P.G., Cardin R.D., Christensen J.P., and Doherty P.C. Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J. Gen. Virol. 80 Pt. 2 (1999) 477-483
40. Stevenson P.G., May J.S., Smith X.G., Marques S., Adler H., Koszinowski U.H., Simas J.P., and Efstathiou S. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat. Immunol. 3 (2002) 733-740
41. Sunil-Chandra N.P., Efstathiou S., and Nash A.A. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73 (1992) 3275-3279
42. Tibbetts S.A., Van Dyk L., Speck S.H., and Virgin H.W. Immune control of the number and reactivation phenotype of cells latently infected with a gamma-herpesvirus. J. Virol. 76 (2002) 7125-7132
43. Tibbetts S.A., Loh J., van B.V., McClellan J.S., Jacoby M.A., Kapadia S.B., Speck S.H., and Virgin H.W. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J. Virol. 77 (2003) 7696-7701
44. Tibbetts S.A., McClellan J.S., Gangappa S., Speck S.H., and Virgin H.W. Effective vaccination against long-term gammaherpesvirus latency. J. Virol. 77 (2003) 2522-2529
45. Usherwood E.J., Roy D.J., Ward K., Surman S.L., Dutia B.M., Blackman M.A., Stewart J.P., and Woodland D.L. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J. Exp. Med. 192 (2000) 943-952
46. van Berkel V., Levine B., Kapadia S.B., Goldman J.E., Speck S.H., and Virgin H.W. Critical role for a high affinity chemokine binding protein in lethal meningitis caused by a g-herpesvirus. J. Clin. Invest. 109 7 (2002) 905-914 (April 1)
47. Van Dyk L.F., Virgin H.W., and Speck S.H. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J. Virol. 74 (2000) 7451-7461
48. van Parijs L., Refaeli Y., Lord J.D., Nelson B.H., Abbas A.K., and Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11 (1999) 281-288
49. Weck K.E., Barkon M.L., Yoo L.I., Speck S.H., and Virgin H.W. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J. Virol. 70 (1996) 6775-6780
50. Weck K.E., Kim S.S., Virgin H.W., and Speck S.H. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 73 (1999) 4651-4661
51. Weibel R.E., Neff B.J., Kuter B.J., Guess H.A., Rothenberger C.A., Fitzgerald A.J., Connor K.A., McLean A.A., Hilleman M.R., and Buynak E.B. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N. Engl. J. Med. 310 (1984) 1409-1415
52. Weller S.K., Lee K.J., Sabourin D.J., and Schaffer P.A. Genetic analysis of temperature-sensitive mutants which define the gene for the major herpes simplex virus type 1 DNA-binding protein. J. Virol. 45 (1983) 354-366
53. Wu T.T., Usherwood E.J., Stewart J.P., Nash A.A., and Sun R. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J. Virol. 74 (2000) 3659-3667